James DArecca is a director of Prestige Consumer Healthcare Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
HAEMONETICS CORP
6 May 24
4
Prestige Consumer Healthcare Inc.
3 Aug 23
3
Prestige Consumer Healthcare Inc.
3 Aug 23
4
HAEMONETICS CORP
17 May 23
4
HAEMONETICS CORP
4 May 23
4
HAEMONETICS CORP
18 May 22
4
HAEMONETICS CORP
4 May 22
3
HAEMONETICS CORP
14 Apr 22
4
TherapeuticsMD, Inc.
12 Aug 21
4
TherapeuticsMD, Inc.
2 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 May 24 | HAE Haemonetics | Common Stock | Payment of exercise | Dispose F | No | No | 93.33 | 432 | 40.32 k | 13,670 |
1 Aug 23 | PBH Prestige Consumer Healthcare | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 2,295 | 0.00 | 2,295 |
16 May 23 | HAE Haemonetics | Common Stock | Payment of exercise | Dispose F | No | No | 89.21 | 349 | 31.13 k | 14,102 |
15 May 23 | HAE Haemonetics | Common Stock | Grant | Acquire A | No | No | 0 | 4,205 | 0.00 | 14,451 |
15 May 23 | HAE Haemonetics | NQSO Common Stock | Grant | Acquire A | No | No | 89.16 | 9,502 | 847.20 k | 9,502 |
2 May 23 | HAE Haemonetics | Common Stock | Payment of exercise | Dispose F | No | No | 81.66 | 430 | 35.11 k | 10,246 |